{"id":909910,"date":"2025-11-13T16:47:15","date_gmt":"2025-11-13T21:47:15","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/ascertain-and-the-oncology-institute-co-develop-touchless-ai-automation-for-oncology-administration\/"},"modified":"2025-11-13T16:47:15","modified_gmt":"2025-11-13T21:47:15","slug":"ascertain-and-the-oncology-institute-co-develop-touchless-ai-automation-for-oncology-administration","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/ascertain-and-the-oncology-institute-co-develop-touchless-ai-automation-for-oncology-administration\/","title":{"rendered":"Ascertain and The Oncology Institute Co-Develop \u2018Touchless\u2019 AI Automation for Oncology Administration"},"content":{"rendered":"<h2>\nPartnership deployed touchless prior authorization system in eight weeks, achieving 95% reduction in authorization workload<br \/>\n<\/h2>\n<div class=\"mw_release\">\n<p align=\"left\">CERRITOS, Calif. and NEW YORK, Nov.  13, 2025  (GLOBE NEWSWIRE) &#8212; <strong>Ascertain<\/strong>, a healthcare technology company pioneering agentic AI to automate administrative workflows, and <strong>The Oncology Institute, Inc. (NASDAQ: TOI)<\/strong>, a leading value-based oncology care provider, today announced a co-development partnership to create \u201cnear-touchless\u201d administrative workflows that reduce manual interactions between providers and payers.<\/p>\n<p>The collaboration centers on <strong>Ascertain\u2019s Unified Payer Portal (UPP)<\/strong> \u2014 an AI-powered automation module that streamlines payer-related tasks required ahead of outpatient oncology visits. The system enables near-touchless workflows by automating manual data entry, documentation submission, and payer portal navigation, significantly reducing the administrative effort required to prepare for each patient encounter.<\/p>\n<p>The joint team achieved rapid implementation, going from a signed statement of work to a live early-stage deployment in just <strong>eight weeks<\/strong>. That pace demonstrates both the adaptability of Ascertain\u2019s technology and the strength of the operational partnership between the two organizations.<\/p>\n<p>Since going live in September 2025, the automation has reduced TOI\u2019s office visit authorization\u00a0submission time\u00a0at pilot sites by\u00a0over 80\u00a0percent, freeing hundreds of staff hours each week. As TOI scales this\u00a0solution across all authorization types, the initiative is expected to generate significant efficiencies that could yield up to an estimated $2 million in operating expense savings in 2026. The system now processes prior authorizations across TOI\u2019s 100+\u00a0clinics and affiliate locations, allowing staff to focus\u00a0more time on\u00a0direct patient care.<\/p>\n<p>\n        <strong>Mark Michalski, MD<\/strong>, CEO of Ascertain, said:<\/p>\n<p>\u201cThe Oncology Institute has been a national leader in bringing value-based cancer care to scale, and we are proud to co-develop automation tools that help sustain that mission. This first deployment of our Unified Payer Portal represents just the beginning. Together, we\u2019re proving that administrative work between providers and payers can become truly touchless \u2014 faster, more accurate, and far less burdensome for clinical teams.\u201d<\/p>\n<p>\n        <strong>Daniel Virnich<\/strong>, CEO of The Oncology Institute, said:<\/p>\n<p>\u201cOur partnership with Ascertain reflects TOI\u2019s ongoing focus on operational excellence and efficiency. We\u2019ve seen how thoughtfully applied automation can simplify complex tasks and allow our staff to focus more of their time on supporting patients. This first implementation went live in only eight weeks, and we look forward to continuing to build on that progress with Ascertain\u2019s team.\u201d<\/p>\n<p>\n        <strong>About Ascertain<\/strong>\n      <\/p>\n<p>\n        <strong>Ascertain<\/strong> is a healthcare technology company using <strong>agentic AI<\/strong> to automate complex, forms-heavy administrative workflows in healthcare. The company\u2019s platform replaces manual tasks \u2014 such as payer communications, documentation assembly, and eligibility verification \u2014 with touchless, intelligent automation. Ascertain was founded in partnership with Northwell Health and Aegis Ventures and is backed by Deerfield Management. For more information, visit<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=kyLJ16Rleaqy3dJ1xeB4EsK845uIR-gd1u61-cK1Nn9Fv4A6vGKbYzmj6aaPjNy1gBVmUX0QhU2pfq9e1R1U-mc78wQphYBPAV0iaryMLWI=\" rel=\"nofollow\" target=\"_blank\"><u>www.ascertain.com<\/u><\/a>.<\/p>\n<p>\n        <strong>About The Oncology Institute<\/strong>\n      <\/p>\n<p>Founded in 2007, <strong>The Oncology Institute (NASDAQ: TOI)<\/strong> is advancing oncology by delivering highly specialized, value-based cancer care in the community setting. TOI offers cutting-edge, evidence-based cancer care to a population of approximately 1.9 million patients, including clinical trials, transfusions, and other care delivery models traditionally associated with the most advanced care delivery organizations. With over 180 employed and affiliate clinicians and over 100 clinics and affiliate locations of care across five states and growing, TOI is changing oncology for the better. For more information, visit <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=YupYGXWIZW2xZmMQcsrHWYYYr1UygkEYHciIvN3beV0OU5ypzzFjwZe32_u9DGLn8kyrPk5IqrZVeYaXXZUZyWVRKE7zY3H1daEScm6NiZc1tq_vkGbGYIsQdOET-hsp\" rel=\"nofollow\" target=\"_blank\"><u>www.theoncologyinstitute.com<\/u><\/a>.<\/p>\n<p>\n        <strong>Media Contact:<\/strong><br \/>\n        <br \/>Marisol Sanders<br \/>Ascertain<br \/>201-228-0693<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=fya5gLSvb_TdQrVR7njZA2zvlrepDo9IpvZkTZSAceIN-84yfUNR9JHUimQqqZJBI8GUWV-jArV1UsFFXRMEgDyRlN6ce8X-6u6_RFrppY0=\" rel=\"nofollow\" target=\"_blank\"><u>media@ascertain.com<\/u><\/a><\/p>\n<p>      <img decoding=\"async\" alt=\"\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTU3NTMyNCM3MjU3MTc5IzIyMjQzMDA=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" alt=\"\" src=\"https:\/\/ml.globenewswire.com\/media\/NWY3ODNmZjktMDc0Mi00M2U2LWFhNDgtMTU0ZTQzN2ZhZTM1LTEyMzU4NTMtMjAyNS0xMS0xMy1lbg==\/tiny\/Toi-Management-LLC.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>Partnership deployed touchless prior authorization system in eight weeks, achieving 95% reduction in authorization workload CERRITOS, Calif. and NEW YORK, Nov. 13, 2025 (GLOBE NEWSWIRE) &#8212; Ascertain, a healthcare technology company pioneering agentic AI to automate administrative workflows, and The Oncology Institute, Inc. (NASDAQ: TOI), a leading value-based oncology care provider, today announced a co-development partnership to create \u201cnear-touchless\u201d administrative workflows that reduce manual interactions between providers and payers. The collaboration centers on Ascertain\u2019s Unified Payer Portal (UPP) \u2014 an AI-powered automation module that streamlines payer-related tasks required ahead of outpatient oncology visits. The system enables near-touchless workflows by automating manual data entry, documentation submission, and payer portal navigation, significantly reducing the administrative effort required to prepare for each patient &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/ascertain-and-the-oncology-institute-co-develop-touchless-ai-automation-for-oncology-administration\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Ascertain and The Oncology Institute Co-Develop \u2018Touchless\u2019 AI Automation for Oncology Administration&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-909910","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Ascertain and The Oncology Institute Co-Develop \u2018Touchless\u2019 AI Automation for Oncology Administration - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/ascertain-and-the-oncology-institute-co-develop-touchless-ai-automation-for-oncology-administration\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Ascertain and The Oncology Institute Co-Develop \u2018Touchless\u2019 AI Automation for Oncology Administration - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"Partnership deployed touchless prior authorization system in eight weeks, achieving 95% reduction in authorization workload CERRITOS, Calif. and NEW YORK, Nov. 13, 2025 (GLOBE NEWSWIRE) &#8212; Ascertain, a healthcare technology company pioneering agentic AI to automate administrative workflows, and The Oncology Institute, Inc. (NASDAQ: TOI), a leading value-based oncology care provider, today announced a co-development partnership to create \u201cnear-touchless\u201d administrative workflows that reduce manual interactions between providers and payers. The collaboration centers on Ascertain\u2019s Unified Payer Portal (UPP) \u2014 an AI-powered automation module that streamlines payer-related tasks required ahead of outpatient oncology visits. The system enables near-touchless workflows by automating manual data entry, documentation submission, and payer portal navigation, significantly reducing the administrative effort required to prepare for each patient &hellip; Continue reading &quot;Ascertain and The Oncology Institute Co-Develop \u2018Touchless\u2019 AI Automation for Oncology Administration&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/ascertain-and-the-oncology-institute-co-develop-touchless-ai-automation-for-oncology-administration\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2025-11-13T21:47:15+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTU3NTMyNCM3MjU3MTc5IzIyMjQzMDA=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ascertain-and-the-oncology-institute-co-develop-touchless-ai-automation-for-oncology-administration\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ascertain-and-the-oncology-institute-co-develop-touchless-ai-automation-for-oncology-administration\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Ascertain and The Oncology Institute Co-Develop \u2018Touchless\u2019 AI Automation for Oncology Administration\",\"datePublished\":\"2025-11-13T21:47:15+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ascertain-and-the-oncology-institute-co-develop-touchless-ai-automation-for-oncology-administration\\\/\"},\"wordCount\":558,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ascertain-and-the-oncology-institute-co-develop-touchless-ai-automation-for-oncology-administration\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTU3NTMyNCM3MjU3MTc5IzIyMjQzMDA=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ascertain-and-the-oncology-institute-co-develop-touchless-ai-automation-for-oncology-administration\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ascertain-and-the-oncology-institute-co-develop-touchless-ai-automation-for-oncology-administration\\\/\",\"name\":\"Ascertain and The Oncology Institute Co-Develop \u2018Touchless\u2019 AI Automation for Oncology Administration - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ascertain-and-the-oncology-institute-co-develop-touchless-ai-automation-for-oncology-administration\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ascertain-and-the-oncology-institute-co-develop-touchless-ai-automation-for-oncology-administration\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTU3NTMyNCM3MjU3MTc5IzIyMjQzMDA=\",\"datePublished\":\"2025-11-13T21:47:15+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ascertain-and-the-oncology-institute-co-develop-touchless-ai-automation-for-oncology-administration\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ascertain-and-the-oncology-institute-co-develop-touchless-ai-automation-for-oncology-administration\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ascertain-and-the-oncology-institute-co-develop-touchless-ai-automation-for-oncology-administration\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTU3NTMyNCM3MjU3MTc5IzIyMjQzMDA=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTU3NTMyNCM3MjU3MTc5IzIyMjQzMDA=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ascertain-and-the-oncology-institute-co-develop-touchless-ai-automation-for-oncology-administration\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Ascertain and The Oncology Institute Co-Develop \u2018Touchless\u2019 AI Automation for Oncology Administration\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Ascertain and The Oncology Institute Co-Develop \u2018Touchless\u2019 AI Automation for Oncology Administration - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/ascertain-and-the-oncology-institute-co-develop-touchless-ai-automation-for-oncology-administration\/","og_locale":"en_US","og_type":"article","og_title":"Ascertain and The Oncology Institute Co-Develop \u2018Touchless\u2019 AI Automation for Oncology Administration - Market Newsdesk","og_description":"Partnership deployed touchless prior authorization system in eight weeks, achieving 95% reduction in authorization workload CERRITOS, Calif. and NEW YORK, Nov. 13, 2025 (GLOBE NEWSWIRE) &#8212; Ascertain, a healthcare technology company pioneering agentic AI to automate administrative workflows, and The Oncology Institute, Inc. (NASDAQ: TOI), a leading value-based oncology care provider, today announced a co-development partnership to create \u201cnear-touchless\u201d administrative workflows that reduce manual interactions between providers and payers. The collaboration centers on Ascertain\u2019s Unified Payer Portal (UPP) \u2014 an AI-powered automation module that streamlines payer-related tasks required ahead of outpatient oncology visits. The system enables near-touchless workflows by automating manual data entry, documentation submission, and payer portal navigation, significantly reducing the administrative effort required to prepare for each patient &hellip; Continue reading \"Ascertain and The Oncology Institute Co-Develop \u2018Touchless\u2019 AI Automation for Oncology Administration\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/ascertain-and-the-oncology-institute-co-develop-touchless-ai-automation-for-oncology-administration\/","og_site_name":"Market Newsdesk","article_published_time":"2025-11-13T21:47:15+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTU3NTMyNCM3MjU3MTc5IzIyMjQzMDA=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ascertain-and-the-oncology-institute-co-develop-touchless-ai-automation-for-oncology-administration\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ascertain-and-the-oncology-institute-co-develop-touchless-ai-automation-for-oncology-administration\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Ascertain and The Oncology Institute Co-Develop \u2018Touchless\u2019 AI Automation for Oncology Administration","datePublished":"2025-11-13T21:47:15+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ascertain-and-the-oncology-institute-co-develop-touchless-ai-automation-for-oncology-administration\/"},"wordCount":558,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ascertain-and-the-oncology-institute-co-develop-touchless-ai-automation-for-oncology-administration\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTU3NTMyNCM3MjU3MTc5IzIyMjQzMDA=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ascertain-and-the-oncology-institute-co-develop-touchless-ai-automation-for-oncology-administration\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/ascertain-and-the-oncology-institute-co-develop-touchless-ai-automation-for-oncology-administration\/","name":"Ascertain and The Oncology Institute Co-Develop \u2018Touchless\u2019 AI Automation for Oncology Administration - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ascertain-and-the-oncology-institute-co-develop-touchless-ai-automation-for-oncology-administration\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ascertain-and-the-oncology-institute-co-develop-touchless-ai-automation-for-oncology-administration\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTU3NTMyNCM3MjU3MTc5IzIyMjQzMDA=","datePublished":"2025-11-13T21:47:15+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ascertain-and-the-oncology-institute-co-develop-touchless-ai-automation-for-oncology-administration\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/ascertain-and-the-oncology-institute-co-develop-touchless-ai-automation-for-oncology-administration\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ascertain-and-the-oncology-institute-co-develop-touchless-ai-automation-for-oncology-administration\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTU3NTMyNCM3MjU3MTc5IzIyMjQzMDA=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTU3NTMyNCM3MjU3MTc5IzIyMjQzMDA="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ascertain-and-the-oncology-institute-co-develop-touchless-ai-automation-for-oncology-administration\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Ascertain and The Oncology Institute Co-Develop \u2018Touchless\u2019 AI Automation for Oncology Administration"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/909910","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=909910"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/909910\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=909910"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=909910"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=909910"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}